Scientific publication by Dr Ewa Chomać-Pierzecka on the development of pharmaceutical companies.

Ewa Chomać-Pierzecka, PhD, published an article entitled 'Innovation as an Attribute of the Sustainable Development of Pharmaceutical Companies' in the journal Sustainability (2025, 17, 2417). The article addresses the topic of innovation as a key element in the sustainability of pharmaceutical companies. In particular, research confirms that investing in innovation contributes to better sustainability performance by enhancing environmental safety, responding to societal expectations and maximising the economic efficiency of operations.

The article also discusses how product innovation is the foundation in achieving competitiveness in the market, and its implementation allows companies to respond effectively to changing market demands. Research indicates that companies that invest more heavily in innovation achieve higher results in terms of sustainability, which influences adaptation to global trends and their further development.

Magazine Sustainability (ISSN: 2071-1050) is indexed in databases such as Scopus, SCIE & SSCI, Geobase, GeoRef, Inspec, RePEc, CAPlus/SCIFinder, with an Impact Factor of 3.3 and a Citescore of 6.8. The article has a MEN score of 100 points.

The full article is available at the link: Innovation as an Attribute of the Sustainable Development of Pharmaceutical Companies .